Investor Presentaiton slide image

Investor Presentaiton

Transaction Overview and Pro Forma Equity Ownership Transaction Structure • . • • CRIS and EVgo anticipate entering into a business combination agreement by January 22, 2021 The transaction would thereafter be expected to close in Q2 2021 Post-closing, the combined company will be listed on the Nasdaq and retain the name, "EVgo" Transaction will utilize Up-C structure and include a tax receivable agreement Valuation • . Transaction reflects a ~$2.6bn post-money equity valuation for EVgo, representing a highly attractive opportunity to invest in a leader in the EV charging space Proceeds from transaction will be used to capitalize the balance sheet with $575mm, and will be primarily used to fund the buildout of its charging infrastructure network(1) Capital Structure • . The transaction will be funded by a combination of $230mm cash held in trust and $400mm in PIPE proceeds (1) All-primary transaction; existing EVgo shareholders, including management, are rolling their equity and are expected to collectively own ~74% of the pro forma company at closing Sources & Uses (1) Pro Forma Valuation (1)(3) ($ in millions) Share price $10.00 Pro forma shares outstanding (mm) 263.1 $2,631 Equity value Plus: debt Less: cash to balance sheet Enterprise value Pro Forma Post Money Ownership(1)(3) Existing EVgo Shareholders 74.4% (575) $2,056 PIPE Investors 15.2% O CRIS Shareholders 8.7% CRIS Sponsor Shares 1.6% ($ in millions) Sources Uses CRIS Trust (2 $230 Rollover equity $1,958 Rollover equity PIPE Founder shares 1,958 400 43 Cash to balance sheet 575 Fees & other transaction expenses Founder shares 55 43 Total sources $2,631 Total uses $2,631 1) 2) Cash in Trust value as of 9/30/20. 3) Assumes no redemptions from the public shareholders of CRIS. Values shown assuming $10 per CRIS shares for illustrative purposes; does not include impact of 1.4 million shares of sponsor earn-out, 11.5mm public out-of-the-money warrants or 6.6mm Sponsor out-of-the-money warrants. EVgo 28
View entire presentation